Author: Maurie Markman, MD,, Vice President for Clinical Research, Professor of Cancer Medicine, University of Texas M D Anderson Cancer Center
Contributor Information and Disclosures
Updated: Jun 30, 2009
Overview
One actively investigated approach in the management of advanced and metastatic colorectal cancer (CRC) has been the delivery of agents whose primary purpose is to interfere with the biological [...]
